DE60014358D1 - Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung - Google Patents

Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung

Info

Publication number
DE60014358D1
DE60014358D1 DE60014358T DE60014358T DE60014358D1 DE 60014358 D1 DE60014358 D1 DE 60014358D1 DE 60014358 T DE60014358 T DE 60014358T DE 60014358 T DE60014358 T DE 60014358T DE 60014358 D1 DE60014358 D1 DE 60014358D1
Authority
DE
Germany
Prior art keywords
org
concept
prevention
hormone therapy
combined intermittent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60014358T
Other languages
English (en)
Inventor
Bennink Jan Coelingh
Hermanus Deckers
Peter Dols
Otto Orlemans
Gerardus Schoonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE60014358D1 publication Critical patent/DE60014358D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE60014358T 1999-04-29 2000-04-25 Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung Expired - Lifetime DE60014358D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201390 1999-04-29
PCT/EP2000/003747 WO2000066129A2 (en) 1999-04-29 2000-04-25 Use of antiprogestagens in combined therapy

Publications (1)

Publication Number Publication Date
DE60014358D1 true DE60014358D1 (de) 2004-11-04

Family

ID=8240174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014358T Expired - Lifetime DE60014358D1 (de) 1999-04-29 2000-04-25 Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung

Country Status (22)

Country Link
EP (1) EP1178807B1 (de)
JP (1) JP2002543136A (de)
KR (1) KR20010110807A (de)
CN (1) CN1349405A (de)
AT (1) ATE277618T1 (de)
AU (1) AU771059B2 (de)
BR (1) BR0010070A (de)
CA (1) CA2371635A1 (de)
CZ (1) CZ20013874A3 (de)
DE (1) DE60014358D1 (de)
HK (1) HK1041834A1 (de)
HU (1) HUP0201875A3 (de)
IL (1) IL145940A0 (de)
MX (1) MXPA01010976A (de)
NO (1) NO20015207D0 (de)
NZ (1) NZ514895A (de)
PL (1) PL351678A1 (de)
RU (1) RU2234321C2 (de)
SK (1) SK15502001A3 (de)
TR (1) TR200103116T2 (de)
WO (1) WO2000066129A2 (de)
ZA (1) ZA200108741B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009017990B4 (de) 2009-04-21 2022-04-07 Valeo Systèmes d'Essuyage Flachwischblatt

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
WO1993021926A1 (en) * 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
ZA935617B (en) * 1992-08-14 1994-03-07 Akzo Nv Antiprogestogen containing contraceptives.
KR20000022189A (ko) * 1996-06-25 2000-04-25 에프.지.엠. 헤르만스;이.에이치. 리링크 프로제스토젠-항프로제스토젠 섭생

Also Published As

Publication number Publication date
HK1041834A1 (zh) 2002-07-26
AU4120400A (en) 2000-11-17
KR20010110807A (ko) 2001-12-13
ZA200108741B (en) 2003-07-23
HUP0201875A2 (en) 2002-10-28
AU771059B2 (en) 2004-03-11
JP2002543136A (ja) 2002-12-17
HUP0201875A3 (en) 2003-10-28
IL145940A0 (en) 2002-07-25
NO20015207L (no) 2001-10-25
MXPA01010976A (es) 2002-07-22
CN1349405A (zh) 2002-05-15
NO20015207D0 (no) 2001-10-25
RU2234321C2 (ru) 2004-08-20
CZ20013874A3 (cs) 2002-06-12
CA2371635A1 (en) 2000-11-09
SK15502001A3 (sk) 2002-03-05
PL351678A1 (en) 2003-06-02
NZ514895A (en) 2004-06-25
EP1178807A2 (de) 2002-02-13
TR200103116T2 (tr) 2002-04-22
EP1178807B1 (de) 2004-09-29
WO2000066129A3 (en) 2001-04-19
WO2000066129A2 (en) 2000-11-09
ATE277618T1 (de) 2004-10-15
BR0010070A (pt) 2002-01-15

Similar Documents

Publication Publication Date Title
DK2455083T3 (da) Farmaceutisk sammensætning til dermal anvendelse omfattende calcipotriol og betamethason til behandling af psoriasis
ATE320436T1 (de) Dimere pyrrolobenzodiazepine
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
ITRM910922A1 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
ES2160707T3 (es) Composiciones que comprenden agentes deteriorantes del adn y p53.
CY1106156T1 (el) Νεα χρηση βουδεσονιδης και φορμοτepολης
DE69710065D1 (de) Androsten-derivate
EE9900036A (et) Uued ühendid ja kompositsioonid trüptaasi aktiivsusega seotud haiguste raviks
MY138883A (en) Use of asiatic acid for treatment of cencer
EE04055B1 (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks, ja nende kasutamine
GB9907571D0 (en) Compounds
DE69832722D1 (de) L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
DE60014358D1 (de) Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
BR9810387A (pt) (s) 3, 4, 5-trimetoxibenzoato de 2-metilamino-2-fenil-n-butila, e sua aplicação para o tratamento de dor crÈnica
DE59502325D1 (de) Arzneimittelszusammensetzung aus S-Milchsäure und dessen Verwendung
WO1999003509A3 (de) Pharmazeutische mittel enthaltend perfluoralkylgruppenhaltige trijodaromaten und ihre verwendung in der tumortherapie und interventionellen radiologie
HUP0300313A3 (en) Compound, pharmaceutical composition containing it and its use for the treatment of pain
ITRM920516A0 (it) Composizione e suo uso per il trattamento terapeutico di affezioni dermatitiche, particolarmente la psoriasi.
SE9803271D0 (sv) A drug for well-being
ZA914000B (en) Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
IL98276A0 (en) Use of anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis

Legal Events

Date Code Title Description
8332 No legal effect for de